TIMP3 rs11803152: Macular Dystrophy Genetics
The genetic variant rs11803152 is a rare variation located in the signal sequence region of the TIMP3 gene. Scientific investigations associate alterations in this peptide sequence with abnormal protein cleavage and atypical forms of macular dystrophy. Understanding this locus sheds light on the biological mechanisms governing retinal matrix health and vision preservation.
What each genotype means
Typical TIMP3 genotype
This is the most common genotype for this location in the TIMP3 gene. It is considered the reference sequence, meaning it does not carry the specific variant associated with the atypical macular dystrophy described in clinical literature.
This is the predominant genotype found in the vast majority of the global population.
Variant carrier status
Carrying one copy of this variant in the TIMP3 signal sequence region has been associated in research with abnormal protein cleavage and atypical macular dystrophy. Because this condition is typically inherited in an autosomal dominant manner, individuals with this genotype should consult with an ophthalmologist or genetic counselor to discuss potential clinical implications for their vision health.
This genotype is rare, occurring in less than 0.1% of the population according to gnomAD data.
Homozygous variant status
Carrying two copies of this variant is extremely rare and is associated with the potential for significant disruption in TIMP3 protein function. Given the association of TIMP3 variants with macular degenerative diseases, individuals with this genotype should seek professional evaluation from an eye care specialist to monitor for signs of retinal or macular changes.
This genotype is exceptionally rare, with a frequency significantly lower than 0.001 in global populations.
Genomic Location and Variant Characteristics
The variant rs11803152 is located within the human TIMP3 gene, positioned on the short arm of chromosome 22. In molecular biology, this variant maps to the critical N-terminal signal sequence of the encoded protein. The signal sequence acts like a biological postal code, directing the newly synthesized protein into the secretory pathway of the cell where it can be properly processed and sent to the extracellular matrix. Unlike classical pathogenic variants that introduce an odd cysteine residue directly into the mature functional domains of the protein, sequence variations in this signal region disrupt the normal machinery responsible for enzymatic peptide cleavage. As cataloged in genomic databases such as dbSNP and ClinVar, changes here alter how the immature precursor molecule transitions into its final structural form, leading to cellular processing anomalies.
The Biological Role of the TIMP3 Gene
The TIMP3 gene encodes tissue inhibitor of metalloproteinases 3, an essential regulatory protein secreted by retinal pigment epithelial (RPE) cells and vascular endothelial cells. Within the eye, TIMP-3 resides predominantly in Bruch's membrane, a specialized extracellular matrix separating the retina from the choroidal blood supply. TIMP-3 performs dual crucial tasks: it restrains matrix metalloproteinases (MMPs) to control the structural turnover of extracellular collagen, and it suppresses unnecessary vessel proliferation by blocking vascular endothelial growth factor receptor 2 (VEGFR2). When TIMP-3 is properly processed and cleared, Bruch's membrane remains permeable, enabling continuous nutrient and waste exchange between the photoreceptor cells and the systemic circulation. Disruptions to TIMP-3 production, structure, or trafficking cause abnormal protein-lipid accumulation underneath the retina, severely impairing vision.
Clinical Evidence and Phenotypic Associations
Mutations in TIMP3 classically cause Sorsby fundus dystrophy (SFD), a rare, autosomal-dominant form of inherited macular degeneration characterized by choroidal neovascularization, lipid-rich drusen deposits, and mid-life central vision loss. However, research into signal peptide region variations like rs11803152 indicates that abnormal cleavage variants often produce an atypical retinal dystrophy phenotype that deviates from classic SFD. Rather than following textbook disease progression driven by unpaired cysteine dimerization, signal peptide variants may lead to early-onset or divergent patterns of retinal atrophy and Bruch's membrane dysfunction. The clinical evidence for rs11803152 remains moderate, defined by pedigree studies, functional cleavage assays, and targeted ophthalmologic evaluations that show altered protein trafficking correlated with degenerative fundus changes.
Population Frequency and Allelic Distribution
Across broad global populations documented in reference resources like the Genome Aggregation Database (gnomAD), rs11803152 is an extremely rare allele, exhibiting a minor allele frequency well below 0.001 (less than 0.1%). The vast majority of individuals across all continental ancestries—including European, African, East Asian, and admixed populations—carry the reference genotype and do not possess the rare alternative allele. Because inherited dominant retinal dystrophies linked to TIMP3 are individually uncommon conditions, variants conferring high-impact biological changes are subject to strong negative selective pressure. Consequently, the rare genotype is virtually absent in routine general screening cohorts and is typically identified only in families or individuals undergoing specialized ophthalmic genetic testing panels for unexplained macular or fundus degenerations.
Navigating Genetic Findings and Retinal Care
Identifying a rare finding like rs11803152 on an exome sequencing report provides biological information rather than an immediate medical diagnosis. A genetic variant indicates statistical and molecular risk, but penetrance, environmental influences, and personal clinical history dictate actual outcomes. Individuals who discover they carry a variant in the TIMP3 gene should not panic, nor should they attempt to self-treat or change their health regimens without guidance. The most effective next step is consulting a licensed genetic counselor or a retinal specialist. Clinicians use sophisticated imaging tools—such as optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA)—to directly visualize Bruch's membrane and detect any early vascular changes, ensuring timely medical management if signs of macular disease emerge.
How common is this variant?
The variant rs11803152 is an ultra-rare allele globally, appearing at an allele frequency of less than 0.001 (<0.1%) across ancestral cohorts in the gnomAD database.
Frequently asked questions
Does carrying rs11803152 mean I will definitely lose my vision?
No, carrying a variant associated with macular dystrophy does not guarantee vision loss. While TIMP3 alterations elevate the statistical risk of retinal changes, phenotypic expression can vary depending on individual biology, lifestyle, and other genetic modifiers. Regular examinations with an ophthalmologist can detect structural changes long before vision is significantly impaired.
How is rs11803152 different from typical Sorsby fundus dystrophy variants?
Classic Sorsby fundus dystrophy mutations typically substitute cysteine residues within the mature protein, causing misfolded dimers. In contrast, variants like rs11803152 lie in the signal peptide region, causing improper cleavage and secretion defects, which often manifest as atypical retinal phenotypes.
Can routine genetic testing kits detect rs11803152?
Most direct-to-consumer genotyping arrays focus only on common variants and often omit rare alleles like rs11803152. Detection of this variant generally requires clinical-grade targeted gene sequencing panels or comprehensive whole-exome sequencing analyzed by a certified laboratory.
What medical tests should someone with a TIMP3 variant receive?
Individuals identified with a TIMP3 variant typically undergo comprehensive retinal evaluations. These assessments frequently utilize optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) to screen for subretinal drusenoid deposits or abnormal new blood vessel growth.
Sources & further reading
Educational information only, last refreshed 9/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11803152?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TIMP3
Encodes the Ser181Cys mutation in TIMP3, a classic pathogenic driver of Sorsby fundus dystrophy leading to premature macular choroidal neovascularization.
Pathogenic missense substitution (p.Ser181Cys) in TIMP3 causing Sorsby fundus dystrophy, leading to choroidal neovascularization and macular degeneration.
Pathogenic missense variant (p.Ser181Cys) in TIMP3 causing classic Sorsby fundus dystrophy characterized by choroidal neovascularization and macular degeneration.